Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life.
Siri A EikelandKnut B SmelandFloortje MolsUnn-Merete FagerliHanne S BersvendsenCecilie E KiserudAlexander FossåPublished in: Acta oncologica (Stockholm, Sweden) (2021)
HL survivors more than a decade after treatment report higher neuropathy-related symptom burden than controls, with a negative impact on HRQoL. Symptoms may be related to factors other than neurotoxic chemotherapy.